Kahan BD - Search Results

1

The Neoral formulation: improved correlation between cyclosporine trough levels and exposure in stable renal transplant recipients.

Kahan BD, Dunn J, Fitts C, Van Buren D, Wombolt D, Pollak R, Carson R, Alexander JW, Chang C, Choc M, et al. Kahan BD, et al. Transplant Proc. 1994 Oct;26(5):2940-3. Transplant Proc. 1994. PMID: 7940928 Clinical Trial. No abstract available.

2

Lipid abnormalities in renal transplant recipients treated with cyclosporine.

Vathsala A, Weinberg RB, Schoenberg L, Grevel J, Dunn J, Goldstein RA, Van Buren CT, Lewis RM, Kahan BD. Vathsala A, et al. Among authors: kahan bd. Transplant Proc. 1989 Aug;21(4):3670-3. Transplant Proc. 1989. PMID: 2669278 No abstract available.

3

Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals.

Kahan BD, Dunn J, Fitts C, Van Buren D, Wombolt D, Pollak R, Carson R, Alexander JW, Choc M, Wong R, et al. Kahan BD, et al. Transplantation. 1995 Feb 27;59(4):505-11. Transplantation. 1995. PMID: 7878754 Clinical Trial.

4

Absence of tumor transmission from a cadaveric renal donor with malignant astrocytoma and a ventriculoperitoneal shunt--two-year recipient follow-up and review of the literature.

Delhey K, Lewis R, Dunn J, Berry J, Gray R, Van Buren C, Kahan B. Delhey K, et al. Transplantation. 1991 Oct;52(4):737-8. Transplantation. 1991. PMID: 1926357 Review. No abstract available.

5

The impact of steady-state cyclosporine concentrations on renal allograft outcome.

Dunn J, Grevel J, Napoli K, Lewis RM, Van Buren CT, Kahan BD. Dunn J, et al. Among authors: kahan bd. Transplantation. 1990 Jan;49(1):30-4. doi: 10.1097/00007890-199001000-00007. Transplantation. 1990. PMID: 2301023

6

Causes of graft loss beyond two years in the cyclosporine era.

Dunn J, Golden D, Van Buren CT, Lewis RM, Lawen J, Kahan BD. Dunn J, et al. Among authors: kahan bd. Transplantation. 1990 Feb;49(2):349-53. doi: 10.1097/00007890-199002000-00024. Transplantation. 1990. PMID: 2305464

7

Impact of race on the outcome of renal transplantation under cyclosporine-prednisone.

Dunn J, Vathsala A, Golden D, Kerman R, Lawen J, Van Buren CT, Lewis R, Kahan BD. Dunn J, et al. Among authors: kahan bd. Transplant Proc. 1989 Dec;21(6):3946-8. Transplant Proc. 1989. PMID: 2609413 No abstract available.

8

Role of cyclosporine: present and future.

Kahan BD. Kahan BD. Transplant Proc. 1994 Oct;26(5):3082-7. Transplant Proc. 1994. PMID: 7940967 Review. No abstract available.

9

Case study: de novo application of Neoral in renal transplantation.

Kahan BD. Kahan BD. Transplant Proc. 1996 Aug;28(4):2189-91; discussion 2192, 2195. Transplant Proc. 1996. PMID: 8769196 No abstract available.

10

Evolution of renal function in cardiac vs. renal allograft recipients receiving long-term cyclosporine A (CsA) immunosuppressive therapy.

Lewis RM, Van Buren CT, Macris M, Frazier OH, Janney RP, McAndrew J, Kerman RH, Kahan BD. Lewis RM, et al. Among authors: kahan bd. Transplant Proc. 1989 Feb;21(1 Pt 2):1523-4. Transplant Proc. 1989. PMID: 2652490 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

715 results

Search Page

Filters